Journey Medical Corp Cash Flow-to-Debt Ratio
Journey Medical Corp cash flow-to-debt ratio. Journey Medical Corp (DERM) has a Cash Flow-to-Debt Ratio of -0.10x as of December 2025, meaning its operating cash flow of $-6.36 Million could theoretically repay 0% of its total liabilities ($62.74 Million) in one year. Check how high is Journey Medical Corp's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Journey Medical Corp (2014–2025)
Cash flow-to-debt ratio of Journey Medical Corp from 2014 to 2025. Historical debt coverage capacity for Journey Medical Corp across 12 annual periods. Check Journey Medical Corp total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Journey Medical Corp Cash Flow-to-Debt Ratio by Year (2014–2025)
Journey Medical Corp cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Journey Medical Corp. For the full cash flow conversion analysis, see Journey Medical Corp (DERM) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.20x | $-12.44 Million | $62.74 Million | ▼ -30.7% |
| 2024 | -0.15x | $-9.13 Million | $60.17 Million | ▼ -263.5% |
| 2023 | 0.09x | $5.24 Million | $56.50 Million | ▲ +160.4% |
| 2022 | -0.15x | $-13.53 Million | $88.18 Million | ▼ -288.8% |
| 2021 | -0.04x | $-2.18 Million | $55.24 Million | ▼ -132.0% |
| 2020 | 0.12x | $5.13 Million | $41.61 Million | ▼ -57.5% |
| 2019 | 0.29x | $9.02 Million | $31.11 Million | ▲ +148.1% |
| 2018 | -0.60x | $-213.10 Million | $353.36 Million | ▼ -138.5% |
| 2017 | -0.25x | $-103.96 Million | $411.14 Million | ▲ +77.7% |
| 2016 | -1.14x | $-74.11 Million | $65.23 Million | ▲ +14.5% |
| 2015 | -1.33x | $-48.44 Million | $36.46 Million | ▼ -4.3% |
| 2014 | -1.27x | $-31.40 Million | $24.64 Million | — |